Do HIV disease progression and HAART response vary among injecting drug users in Europe?

L. VAN ASTEN ; R. ZANGERLE ; I. HERNANDEZ-AGUADO ; F. BOUFASSA ; B. BROERS ; R. BRETTLE ; J. ROY ROBERTSON ; J. MCMENAMIN ; R. COUTINHO ; M. PRINS | 2005
Dans European Journal of Epidemiology (Vol.20, n°9, September 2005) Article : Périodique

Prior to HAART availability, there was no evidence of a geographical variation in HIV disease progression among injecting drug users (IDU) from different European regions. Nowadays, factors of importance regarding HIV disease progression in the [...]

Plus d'info

Ajouter à la sélection

Tuberculosis risk varies with the duration of HIV infection: a prospective study of european drug users with known date of HIV seroconversion

L. VAN ASTEN ; M. LANGENDAM ; R. ZANGERLE ; I. HERNANDEZ-AGUADO ; F. BOUFASSA ; V. SCHIFFER ; R. P. BRETTLE ; J. ROY ROBERTSON ; FONTANET A. ; R. A. COUTINHO ; M. PRINS | 2003
Périodique

ENGLISH : Background: It is not known whether the risk of active tuberculosis disease varies with the length of time that individuals are infected with HIV. Objective: To study how, independently of CD4 T cell count, the risk of tuberculosis v[...]

Plus d'info

Ajouter à la sélection